PIM kinase inhibition: co-targeted therapeutic approaches in prostate cancer

por Luszczak, Sabina, Kumar, Christopher, Sathyadevan, Vignesh Krishna, Simpson, Benjamin S., Gately, Kathy A., Whitaker, Hayley C., Heavey, Susan
Publicado 2020

Activation and cleavage of SASH1 by caspase-3 mediates an apoptotic response

por Burgess, Joshua T, Bolderson, Emma, Adams, Mark N, Baird, Anne-Marie, Zhang, Shu-Dong, Gately, Kathy A, Umezawa, Kazuo, O'Byrne, Kenneth J, Richard, Derek J
Publicado 2016

Co-targeting PIM and PI3K/mTOR using multikinase inhibitor AUM302 and a combination of AZD-1208 and BEZ235 in prostate cancer

por Luszczak, Sabina, Simpson, Benjamin S., Stopka-Farooqui, Urszula, Sathyadevan, Vignesh Krishna, Echeverria, Lina M. Carmona, Kumar, Christopher, Costa, Helena, Haider, Aiman, Freeman, Alex, Jameson, Charles, Ratynska, Marzena, Ben-Salha, Imen, Sridhar, Ashwin, Shaw, Greg, Kelly, John D., Pye, Hayley, Gately, Kathy A., Whitaker, Hayley C., Heavey, Susan
Publicado 2020

Author Correction: Co-targeting PIM and PI3K/mTOR using multikinase inhibitor AUM302 and a combination of AZD-1208 and BEZ235 in prostate cancer

por Luszczak, Sabina, Simpson, Benjamin S., Stopka-Farooqui, Urszula, Sathyadevan, Vignesh Krishna, Echeverria, Lina M. Carmona, Kumar, Christopher, Costa, Helena, Haider, Aiman, Freeman, Alex, Jameson, Charles, Ratynska, Marzena, Ben-Salha, Imen, Sridhar, Ashwin, Shaw, Greg, Kelly, John D., Pye, Hayley, Gately, Kathy A., Whitaker, Hayley C., Heavey, Susan
Publicado 2020